FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 01/01/2019 |
3. Issuer Name and Ticker or Trading Symbol
HCA Healthcare, Inc. [ HCA ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 6,871 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Appreciation Right | (1) | 11/06/2023 | Common Stock | 1,750 | $45.3 | D | |
Stock Appreciation Right | (2) | 11/06/2023 | Common Stock | 2,250 | $45.3 | D | |
Stock Appreciation Right | (3) | 02/05/2024 | Common Stock | 2,625 | $47.97 | D | |
Stock Appreciation Right | (4) | 02/05/2024 | Common Stock | 2,100 | $47.97 | D | |
Stock Appreciation Right | (5) | 02/04/2025 | Common Stock | 5,000 | $68.96 | D | |
Stock Appreciation Right | (6) | 01/29/2026 | Common Stock | 3,760 | $69.58 | D | |
Stock Appreciation Right | (7) | 02/01/2027 | Common Stock | 4,040 | $81.96 | D | |
Stock Appreciation Right | (8) | 01/31/2028 | Common Stock | 5,040 | $101.16 | D | |
Stock Appreciation Right | (9) | 10/31/2028 | Common Stock | 13,730 | $133.53 | D |
Explanation of Responses: |
1. The stock appreciation rights vested in four equal annual installments beginning on November 6, 2014. |
2. The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. |
3. The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. |
4. The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. |
5. The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016. |
6. The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017. |
7. The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. |
8. The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. |
9. The stock appreciation rights vest in four equal annual installments beginning on October 31, 2019. |
Remarks: |
/s/ Virginia Chase Crocker, Attorney-in-Fact | 01/10/2019 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |